These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 1913656)
41. Stimulation of epithelial membrane antigen expression by transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells. Walker-Jones D; Valverius EM; Stampfer MR; Lippman ME; Dickson RB Cancer Res; 1989 Nov; 49(22):6407-11. PubMed ID: 2680064 [TBL] [Abstract][Full Text] [Related]
42. Reversal of transformed phenotypes by herbimycin A in src oncogene expressed rat fibroblasts. Murakami Y; Mizuno S; Hori M; Uehara Y Cancer Res; 1988 Mar; 48(6):1587-90. PubMed ID: 3345529 [TBL] [Abstract][Full Text] [Related]
43. Similar and synergistic inhibition of gap-junctional communication by ras transformation and tumor promoter treatment of mouse primary keratinocytes. Dotto GP; el-Fouly MH; Nelson C; Trosko JE Oncogene; 1989 May; 4(5):637-41. PubMed ID: 2657578 [TBL] [Abstract][Full Text] [Related]
44. Suppression of v-Src transformation in primary rat embryo fibroblasts. Inoue H; Tavoloni N; Hanafusa H Oncogene; 1995 Jul; 11(2):231-8. PubMed ID: 7624140 [TBL] [Abstract][Full Text] [Related]
45. Reversal of ras-induced inhibition of gap-junctional intercellular communication, transformation, and tumorigenesis by lovastatin. Ruch RJ; Madhukar BV; Trosko JE; Klaunig JE Mol Carcinog; 1993; 7(1):50-9. PubMed ID: 8435109 [TBL] [Abstract][Full Text] [Related]
46. Specific viral oncogenes cause differential effects on cell-to-cell communication, relevant to the suppression of the transformed phenotype by normal cells. Bignami M; Rosa S; Falcone G; Tató F; Katoh F; Yamasaki H Mol Carcinog; 1988; 1(1):67-75. PubMed ID: 2475135 [TBL] [Abstract][Full Text] [Related]
47. Homologous and heterologous gap-junctional intercellular communication in v-raf-, v-myc-, and v-raf/v-myc-transduced rat liver epithelial cell lines. Kalimi GH; Hampton LL; Trosko JE; Thorgeirsson SS; Huggett AC Mol Carcinog; 1992; 5(4):301-10. PubMed ID: 1379816 [TBL] [Abstract][Full Text] [Related]
48. [Highly permeable intercellular junctions in normal and transformed fibroblast cultures]. Boĭtsova LIu; Vasil'ev IuM; Potapova TV Tsitologiia; 1975 Mar; 17(3):279-85. PubMed ID: 49116 [TBL] [Abstract][Full Text] [Related]
49. Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid. Davidson JS; Baumgarten IM; Harley EH Biochem Biophys Res Commun; 1986 Jan; 134(1):29-36. PubMed ID: 3947327 [TBL] [Abstract][Full Text] [Related]
50. Stat3 activity is required for gap junctional permeability in normal rat liver epithelial cells. Geletu M; Chaize C; Arulanandam R; Vultur A; Kowolik C; Anagnostopoulou A; Jove R; Raptis L DNA Cell Biol; 2009 Jul; 28(7):319-27. PubMed ID: 19456249 [TBL] [Abstract][Full Text] [Related]
51. Association of viral oncogene-induced changes in gap junctional intercellular communication and morphological transformation in BALB/c3T3 cells. Katoh F; Klein JL; Bignami M; Yamasaki H Carcinogenesis; 1993 Mar; 14(3):435-40. PubMed ID: 8384090 [TBL] [Abstract][Full Text] [Related]
52. Chemical, oncogene and growth factor inhibition gap junctional intercellular communication: an integrative hypothesis of carcinogenesis. Trosko JE; Chang CC; Madhukar BV; Klaunig JE Pathobiology; 1990; 58(5):265-78. PubMed ID: 2076190 [TBL] [Abstract][Full Text] [Related]
53. Infection of rat liver epithelial cells with v-Ha-ras: correlation between oncogene expression, gap junctional communication, and tumorigenicity. De Feijter AW; Ray JS; Weghorst CM; Klaunig JE; Goodman JI; Chang CC; Ruch RJ; Trosko JE Mol Carcinog; 1990; 3(2):54-67. PubMed ID: 2346586 [TBL] [Abstract][Full Text] [Related]
54. Cell-to-cell communication and the control of growth. Loewenstein WR Am Rev Respir Dis; 1990 Dec; 142(6 Pt 2):S48-53. PubMed ID: 2252275 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of gap-junctional intercellular communication between epithelial cells transformed by the activated H-ras-1 oncogene. Vanhamme L; Rolin S; Szpirer C Exp Cell Res; 1989 Jan; 180(1):297-301. PubMed ID: 2535816 [TBL] [Abstract][Full Text] [Related]
56. Suppression and re-expression of transformed phenotype in hybrids of HA-ras-1-transformed rat-1 cells and early-passage rat embryonic fibroblasts. Griegel S; Traub O; Willecke K; Schäfer R Int J Cancer; 1986 Nov; 38(5):697-705. PubMed ID: 3533793 [TBL] [Abstract][Full Text] [Related]
57. Altered junctional permeability between cells transformed by v-ras, v-mos, or v-src. Atkinson MM; Sheridan JD Am J Physiol; 1988 Nov; 255(5 Pt 1):C674-83. PubMed ID: 3056028 [TBL] [Abstract][Full Text] [Related]
58. Suppression of transformed phenotype in hybrids of v-fgr and v-raf transformed rat-1 cells with rat embryonic fibroblasts is due to transcriptional inactivation of viral oncogenes. Martin W; Lenz E; Grohé B; Willecke K Exp Cell Res; 1992 May; 200(1):41-7. PubMed ID: 1563491 [TBL] [Abstract][Full Text] [Related]
59. Potential role of the src gene product in inhibition of gap-junctional communication in NIH/3T3 cells. Chang CC; Trosko JE; Kung HJ; Bombick D; Matsumura F Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5360-4. PubMed ID: 2991919 [TBL] [Abstract][Full Text] [Related]
60. Potential role of the human Ha-ras oncogene in the inhibition of gap junctional intercellular communication. el-Fouly MH; Trosko JE; Chang CC; Warren ST Mol Carcinog; 1989; 2(3):131-5. PubMed ID: 2675903 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]